Medicine for preventing and treating ischemic heart disease of mammals as well as preparation method and application of medicine
A technology of ischemic heart disease and mammals, applied in the field of medicine, to avoid fatal arrhythmia, improve the microenvironment, and improve the effect of survival
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] Embodiment 1: preparation of pharmaceutical composition
[0040]Collect the whole herb of Lanbuzhenghe Potentilla at an altitude of 1000-1400 meters in Guizhou, wash it, and dry it in the shade; or collect the whole herb of fresh Lanbuzhenghe Potentilla at an altitude of 1000-1400 meters in Guizhou and wash it. The above-mentioned fresh grass freeze-dried / natural shade-dried plant raw materials were respectively cut into pieces, and 80% of the blue cloth was mixed with 20% of Potentilla. In the experiment, it was found that the ethanol / water extract of Lanbuzheng not only contains components that induce coronary vascular regeneration in the ischemic area of the heart and rebuilds the cardiac vascular network, but also contains components that damage the liver. And it was found that the liver-damaging component also inhibits the active site from regenerating myocardial tissue with the correct ultrastructure at the site of cardiac injury. In order to remove the liver-h...
Embodiment 2
[0044] Embodiment 2: Promote the formation of blood vessel-like lumen in 3D cell culture of vascular endothelial cells
[0045] The preparation of Ham's F-12 three-dimensional vascular endothelial cell culture medium is briefly as follows: Fibrin was prepared by polymerization of α-thrombin (2.5 units / ml) and fibrinogen solution (5 mg fibrinogen / ml serum-free medium) matrix. After polymerization, the gel was immersed in Ham's F-12 medium containing 10% calf serum and incubated in a 37ºC water bath for 3 hours to inactivate α-thrombin. The active site composition was determined in a three-dimensional vascular endothelial cell culture medium to promote the formation of blood vessel-like lumen structures of human coronary artery endothelial cells (HCAEC) in the culture medium. Inoculate HCAEC on the surface of the three-dimensional culture matrix in a 96-well culture dish, add different concentrations (5-30μg / ml) of the active site composition to treat the target cultured cells,...
Embodiment 3
[0048] Example 3: Animal model of myocardial infarction evaluates the composition of the active site, that is, the pharmaceutical composition
[0049] The therapeutic effect of
[0050] The animal model of myocardial infarction was made by completely ligating the anterior descending coronary artery in rats. Thirty male Sprague-Dawley rats with a body weight of 300-350 grams were injected intraperitoneally with pentobarbital (50 mg / kg body weight) at room temperature to anesthetize the experimental animals, carried out endotracheal intubation and carried out artificial respiration with a small animal ventilator, The left anterior descending (LAD) artery of the heart of the experimental animal was surgically opened, permanently ligated completely, the chest was closed, and the animal was placed in a warm area to wake up and recover to create an animal model of myocardial infarction on the anterior wall of the left ventricle. Three days after LAD ligation, aCGJ (250 mg / kg body w...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com